EUVIMEDEUVIMED entdecken
Crossref

Levamisole as an adjuvant to hepatitis B vaccination in patients with chronic kidney disease

Mohammad-Hossein Somi, Mohammad-Reza Ardalan, Majid Moghadaszadeh, Masoud Shirmohamadi, Reza Piri, Mohammad Naghavi-Behzad

Journal of Analytical Research in Clinical Medicine · 2015

DOI: 10.15171/jarcm.2015.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Analytical Research in Clinical Medicine, 2015. Verfasst von Mohammad-Hossein Somi und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Somi, M., Ardalan, M., Moghadaszadeh, M., Shirmohamadi, M., Piri, R., & Naghavi-Behzad, M. (2015). Levamisole as an adjuvant to hepatitis B vaccination in patients with chronic kidney disease. Journal of Analytical Research in Clinical Medicine. https://doi.org/10.15171/jarcm.2015.013

Vancouver

Somi M, Ardalan M, Moghadaszadeh M, Shirmohamadi M, Piri R, Naghavi-Behzad M. Levamisole as an adjuvant to hepatitis B vaccination in patients with chronic kidney disease. Journal of Analytical Research in Clinical Medicine. 2015. doi:10.15171/jarcm.2015.013

BibTeX
@article{Somi2015,
  author = {Somi, Mohammad-Hossein and Ardalan, Mohammad-Reza and Moghadaszadeh, Majid and Shirmohamadi, Masoud and Piri, Reza and Naghavi-Behzad, Mohammad},
  title = {Levamisole as an adjuvant to hepatitis B vaccination in patients with chronic kidney disease},
  journal = {Journal of Analytical Research in Clinical Medicine},
  year = {2015},
  doi = {10.15171/jarcm.2015.013}
}
Kostenlos starten →